Oncotarget

Editorial Comments:

Bryostatin analog: improving on Nature’s design

Dale Boger _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2012; 3:116-117. https://doi.org/10.18632/oncotarget.460

Metrics: PDF 1194 views  |   HTML 1554 views  |   ?  


Abstract

Commentary on: Dechristopher B et al. “Picolog,” a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo. Oncotarget 2012; 3: 58-66.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 460